ArticleNature communications2020
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2.
Ryota Tamura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it